1. 1616 A double blind, self-controlled randomized trial of prophylactic topical vitamin K1 cream application for cetuximab-related skin toxicity (VANQUISH trial). (September 2015) Authors: Tsushima, T.; Yamazaki, K.; Kato, T.; Taku, K.; Yoshida, Y.; Hamauchi, S.; Yoshikawa, S.; Yagi, H.; Kimura, M.; Ishikawa, H.; Kimura, M.; Nakajo, M.; Sakata, S.; Masujima, H.; Miyazawa, A.; Saitou, K.; Izawa, M.; Iwami, K.; Yamanaka, T.; Kiyohara, Y. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S243 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 2129 Predictive factor for toxicities and treatment termination in adjuvant capecitabine therapy for stage III colorectal cancer; based on the data of a randomized trial, JCOG0910. (September 2015) Authors: Yoshida, Y.; Yamazaki, K.; Mizusawa, J.; Satoh, M.; Hinoi, T.; Tsuchida, A.; Otsuka, K.; Sato, T.; Watanabe, M.; Baba, H.; Kimura, H.; Idani, H.; Kanazawa, A.; Fukunaga, M.; Okuda, J.; Tajima, Y.; Hasegawa, H.; Katayama, H.; Hamaguchi, T.; Shimada, Y. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S375 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 394PA self-controlled trial of prophylactic topical application of vitamin K1 cream for cetuximab-related skin rash. (19th December 2015) Authors: Ishikawa, H.; Kato, T.; Yamazaki, K.; Taku, K.; Tsushima, T.; Yoshida, Y.; Hamauchi, S.; Yoshikawa, S.; Yagi, H.; Kimura, M.; Kimura, M.; Nakajo, M.; Sakata, S.; Masujima, H.; Miyazawa, A.; Izawa, M.; Iwami, K.; Yamanaka, T.; Kiyohara, Y. Journal: Annals of oncology Issue: Volume 26(2015)Supplement 9 Page Start: ix118 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A case of pancreatic ductal adenocarcinoma with portal vein tumor thrombus continuously invading through the posterior superior pancreatico-duodenal vein. (September 2018) Authors: Nakano, H.; Onishi, Y.; Yoshida, Y.; Matsushita, T.; Kobayashi, S.; Otsubo, T. Journal: HPB Issue: Volume 20(2018)Supplement 2 Page Start: S567 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A Major Fimbrilin Variant of Mfa1 Fimbriae in Porphyromonas gingivalis. (August 2015) Authors: Nagano, K.; Hasegawa, Y.; Yoshida, Y.; Yoshimura, F. Journal: Journal of dental research Issue: Volume 94:Number 8(2015:Aug.) Page Start: 1143 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. AB0050 Irf8 Promotes TH17 Differentiation via Activation of Integrin-Mediated Tgfbeta Signaling in Neuroinflammation. (10th June 2014) Authors: Yoshimi, R.; Yoshida, Y.; Yoshii, H.; Kim, D.; Dey, A.; Xiong, H.; Munasinghe, J.; Yazawa, I.; O'Donovan, M.J.; Maximova, O.A.; Sharma, S.; Zhu, J.; Wang, H.; Morse, H.C.; Ishigatsubo, Y.; Ozato, K. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 820 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. AB0114 Semaphorin3a and semaphorin4d in rheumatoid arthritis. (23rd January 2014) Authors: Yoshida, Y.; Kang, S.; Morishima, A.; Akihiko, N.; Hishitani, Y.; Maeda, Y.; Nishide, M.; Hamano, M.; Morimoto, K.; Hirano, T.; Shima, Y.; Narazaki, M.; Tanaka, T.; Ogata, A.; Kumanogoh, A. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A820 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. AB0156 Increased Soluble Semaphorin 4D in Rheumatoid Arthritis. (10th June 2014) Authors: Yoshida, Y.; Ogata, A.; Tomita, T.; Kang, S.; Hirano, T.; Shima, Y.; Narazaki, M.; Tanaka, T.; Kumanogoh, A. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 854 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. AB0452 PREDICTIVE FACTORS FOR INSUFFICIENT RESPONSE TO INITIAL TREATMENT OR RECURRENCE IN PATIENTS WITH LUPUS ENTERITIS. (2nd June 2020) Authors: Yoshida, Y.; Sugimoto, T.; Kohno, H.; Watanabe, H.; Mokuda, S.; Hirata, S.; Sugiyama, E. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 1524 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. AB0498 Optimisation of methotrexate dose induced successful reduction of glucocorticoids without impaired disease control in patients with rheumatoid arthritis. (12th June 2018) Authors: Hirata, S.; Kondo, T.; Yukawa, K.; Tokunaga, T.; Kuranobu, T.; Oi, K.; Yoshida, Y.; Funaki, M.; Oda, K.; Nojima, T.; Sugiyama, E. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 1409 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗